XML 53 R41.htm IDEA: XBRL DOCUMENT
v3.20.2

Revenue - Revenue Recognition (Details) - Revenue Benchmark | 3 Months Ended | 6 Months Ended
--- | --- | ---
Jun. 30, 2020 | Jun. 30, 2019 | Jun. 30, 2020 | Jun. 30, 2019
Customer Concentration Risk |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Percentage of net sales | 100.00% | 100.00% | 100.00% | 100.00%
Product Concentration Risk |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Percentage of net sales | 100.00% | 100.00% | 100.00% | 100.00%
Geographic Concentration Risk |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Percentage of net sales | 100.00% | 100.00% | 100.00% | 100.00%
Americas | Geographic Concentration Risk |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Percentage of net sales | 50.00% | 49.00% | 49.00% | 48.00%
Europe, Middle East, Africa | Geographic Concentration Risk |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Percentage of net sales | 42.00% | 43.00% | 43.00% | 45.00%
Asia Pacific | Geographic Concentration Risk |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Percentage of net sales | 8.00% | 8.00% | 8.00% | 7.00%
High-Value Components | Product Concentration Risk |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Percentage of net sales | 44.00% | 44.00% | 44.00% | 43.00%
Standard Packaging | Product Concentration Risk |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Percentage of net sales | 26.00% | 29.00% | 27.00% | 30.00%
Delivery Devices | Product Concentration Risk |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Percentage of net sales | 6.00% | 4.00% | 5.00% | 4.00%
Contract-Manufactured Products | Product Concentration Risk |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Percentage of net sales | 24.00% | 23.00% | 24.00% | 23.00%
Biologics | Customer Concentration Risk |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Percentage of net sales | 28.00% | 25.00% | 28.00% | 25.00%
Generics | Customer Concentration Risk |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Percentage of net sales | 21.00% | 21.00% | 20.00% | 21.00%
Pharma | Customer Concentration Risk |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Percentage of net sales | 27.00% | 31.00% | 28.00% | 31.00%
Contract-Manufactured Products | Customer Concentration Risk |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Percentage of net sales | 24.00% | 23.00% | 24.00% | 23.00%

X
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 18 -URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 20 -URI http://asc.fasb.org/extlink&oid=121572278&loc=d3e13531-108611 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 20 -URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592 + Details
Name: | us-gaap_ConcentrationRiskPercentage1
Namespace Prefix: | us-gaap_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_DisaggregationOfRevenueLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=srt_AmericasMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=us-gaap_EMEAMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=srt_AsiaPacificMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=wst_HighValueComponentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=wst_StandardPackagingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=wst_DeliveryDevicesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=wst_ContractManufacturedProductsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_MajorCustomersAxis=wst_BiologicsCustomersMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_MajorCustomersAxis=wst_GenericsCustomersMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_MajorCustomersAxis=wst_PharmaCustomersMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_MajorCustomersAxis=wst_ContractManufacturedCustomersMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |